A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus

European Journal of Pediatrics

Volumn 164, Issue 3, 2005, Pages 135-140

  Thomas, Ronald L ^a   Parker, Graham C ^a   Van Overmeire, Bart ^b   Aranda, Jacob V ^a  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Ibuprofen; Indomethacin; Meta analysis; Patent ductus arteriosus

Indexed keywords

CREATININE; IBUPROFEN; INDOMETACIN; OXYGEN; SURFACTANT;

ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ARTICLE; BRAIN HEMORRHAGE; CHILD HOSPITALIZATION; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; ENCEPHALOMALACIA; GASTROINTESTINAL HEMORRHAGE; HEMOCONCENTRATION; HUMAN; INFANT MORTALITY; INTESTINE PERFORATION; LENGTH OF STAY; LIGATION; META ANALYSIS; NECROTIZING ENTEROCOLITIS; ORGAN BLOOD FLOW; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; POSTNATAL CARE; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; SEPSIS; SIDE EFFECT; STATISTICAL SIGNIFICANCE; STOMACH HEMORRHAGE; URINE VOLUME; VASOCONSTRICTION; VENTILATOR;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CREATININE; DUCTUS ARTERIOSUS, PATENT; HUMANS; IBUPROFEN; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; OXYGEN INHALATION THERAPY; RANDOMIZED CONTROLLED TRIALS; URINATION;

EID: 17644417499     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-004-1596-5     Document Type: Article

References (33)

1. Ahlfors CE (2004) Effect of ibuprofen on bilirubin-albumin binding. J Pediatr 144: 386-388
2. Ambat MTC, Ostrea EM Jr, Aranda JV (2002) Influence of ibuprofen L -lysinate (IBU) on bilirubin binding to albumin. Pediatr Res APS-SPR 51: 344A
3. Ambat MTC, Ostrea EM Jr, Aranda JV (2003) Influence of ibuprofen L -lysinate (IBU) on bilirubin albumin binding as determined by the saturation index and horseradish peroxidase tests. Pediatr Res APS-SPR 53: 365A
4. Biostat Inc (1999) Comprehensive Meta-Analysis: a computer program for research synthesis
5. Chemtob S, Laudignon N, Beharry K, Rex J, Varma D, Wolfe L, Aranda JV (1990) Effects of prostaglandins and indomethacin on cerebral blood flow and cerebral oxygen consumption of conscious newborn piglets. Dev Pharmacol Ther 14: 1-14
6. Chemtob S, Beharry K, Barna T, Varma DR, Aranda JV (1991) Differences in the effects in the newborn piglet of various nonsteroidal antiinflammatory drugs on cerebral blood flow but not on cerebrovascular prostaglandins. Pediatr Res 30: 106-111
7. Cohen J (1994) The earth is round (P-less-than.05). American Psychologist 49: 997-1003
8. Cotton RB, Stahlman MT, Bender HW, Graham TP, Catterton WZ, Kovar I (1978) Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr 93: 647-651
9. De Carolis MP, Romagnoli C, Polimeni V, Piersigilli F, Zecca E, Papacci P, Delogu AB, Tortorolo G (2000) Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. Eur J Pediatr 159: 364-368
10. Fowlie PW (2000) Intravenous indomethacin for preventing mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev CD000174
11. Fujii AM, Brown E, Mirochnick M, O'Brien S, Kaufman G (2002) Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus. J Perinatol 22: 535-540
12. Gersony WM (1986) Patent ductus arteriosus in the neonate. Pediatr Clin North Am 33: 545-560
13. Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS (1983) Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 102: 895-906
14. Grosfeld JL, Chaet M, Molinari F, Engle W, Engum SA, West KW, Rescorla FJ, Scherer LR III (1996) Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann Surg 224: 350-355
15. Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, Saia OS (2002) Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr 161: 202-207
16. Laudignon N, Chemtob S, Bard H, Aranda JV (1988) Effect of indomethacin on cerebral blood flow velocity of premature newborns. Biol Neonate 54: 254-262
17. Ment LR, Oh W, Ehrenkranz RA, Philip AG, Vohr B, Allan W, Duncan CC, Scott DT, Taylor KJ, Katz KH (1994) Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 93: 543-550
18. Ment LR, Vohr B, Oh W, Scott DT, Allan WC, Westerveld M, Duncan CC, Ehrenkranz RA, Katz KH, Schneider KC, Makuch RW (1996) Neurodevelopmental outcome at 36 months' corrected age of preterm infants in the Multicenter Indomethacin Intraventricular Hemorrhage Prevention Trial. Pediatrics 98: 714-718
19. Ment LR, Vohr B, Allan W, Westerveld M, Sparrow SS, Schneider KC, Katz KH, Duncan CC, Makuch RW (2000) Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics 105: 485-491
20. Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C (1997) Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 131: 549-554
21. Ohlsson A, Walia R, Shah S (2003) Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev CD003481
22. Patel J, Marks KA, Roberts I, Azzopardi D, Edwards AD (1995) Ibuprofen treatment of patent ductus arteriosus. Lancet 346: 255
23. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD (2000) Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 47: 36-42
24. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli FF (1999) Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 135: 733-738
25. Plavka R, Svihovec P, Borek I, Biolek J, Kostirova M, Liska K, Kopecky P, Sebron V, Zlatohlavkova B, Ruffer J, Dokoupilova M (2001) Ibuprofen vs indomethacin in the treatment of patent ductus arteriosus in very premature neonates. Pediatr Res APS-SPR 49: 375A
26. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, Solimano A, Vincer M, Wright LL (2001) Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 344: 1966-1972
27. Schmidt B, Asztalos EV, Roberts RS, Robertson CM, Sauve RS, Whitfield MF (2003) Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA 289: 1124-1129
28. Su PH, Chen JY, Su CM, Huang TC, Lee HS (2003) Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Pediatr Int 45: 665-670
29. Van Overmeire B, Follens I, Hartmann S, Creten WL, Van Acker KJ (1997) Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child Fetal Neonatal Ed 76: F179-F184
30. Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, De Groote K, Langhendries JP (2000) A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 343: 674-681
31. Van Overmeire B, Vanhagendoren S, Schepens PJ, Ahlfors CE (2004) The influence of ibuprofen-lysine on unbound bilirubin plasma levels in preterm neonates. Pediatr Res APS-SPR 55: 474A
32. Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV (1996) Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 275: 539-544
33. Vohr BR, Allan WC, Westerveld M, Schneider KC, Katz KH, Makuch RW, Ment LR (2003) School-age outcomes of very low birth weight infants in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics 111: e340-e346